AssayIndex
BCH cross-section

BCH by compound

BCH records split by compound, with the index-wide comparison for the same compound beside each one. 25 compounds, 316 records. Cells below n=3 print their raw values instead of a median.

25 compounds316 records
CompoundClassReportsBCH median %Index median %Δ (pp)SpecPass %
SemaglutideIncretin5698.1698.87-0.7197.0100
TirzepatideIncretin3897.4298.44-1.0397.082
MK-677 (Ibutamoren mesylate)Non-peptide2998.1899.37-1.1998.510
BPC-157Tissue-repair2398.2199.15-0.9498.065
CJC-1295 with DACGrowth-hormone2098.1498.79-0.6597.595
L-Glutathione (reduced)Short1697.7699.00-1.2498.513
GHRP-2Growth-hormone1498.6399.22-0.5999.029
MOTS-cMetabolic1298.1399.18-1.0698.058
CagrilintideIncretin1299.1198.59+0.5396.5100
PemvidutideIncretin1297.9898.41-0.4296.0100
AOD-9604Metabolic1198.3099.25-0.9598.073
PT-141 (Bremelanotide)Melanocortin-receptor1199.3199.31-0.0098.5100
MGFGrowth-hormone1098.8998.73+0.1697.5100
CJC-1295 (no DAC)Growth-hormone1098.2998.61-0.3298.090
GonadorelinHypothalamic998.6299.28-0.6698.578
AfamelanotideMelanocortin-receptor997.9799.28-1.3198.044
HexarelinGrowth-hormone6 n=697.8498.72-0.8899.00
GHRP-6Growth-hormone5 n=598.6199.65-1.0499.020
N-Acetyl Semax AmideNeuroactive4 n=497.4799.26-1.8098.50
IpamorelinGrowth-hormone2 n=2n<399.4899.0100
RetatrutideIncretin2 n=2n<398.4196.5100
VIPTissue-repair2 n=2n<398.2297.550
TB-500Tissue-repair1 n=1n<399.4798.5100
SelankNeuroactive1 n=1n<399.1399.0100
Humanin (HNG)Metabolic1 n=1n<399.4797.50
96.196.897.598.298.899.5100.2SemaglutideSemaglutide: Q1 97.77, median 98.16, Q3 98.77, n=56n=56TirzepatideTirzepatide: Q1 97.13, median 97.42, Q3 97.84, n=38outlier 99.14n=38MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 97.89, median 98.18, Q3 98.35, n=29outlier 97.10n=29BPC-157BPC-157: Q1 97.90, median 98.21, Q3 98.44, n=23n=23CJC-1295 with DACCJC-1295 with DAC: Q1 98.01, median 98.14, Q3 98.51, n=20n=20L-Glutathione (reduce…L-Glutathione (reduce…: Q1 97.54, median 97.76, Q3 98.06, n=16outlier 96.39n=16GHRP-2GHRP-2: Q1 98.41, median 98.63, Q3 98.92, n=14n=14MOTS-cMOTS-c: Q1 97.73, median 98.13, Q3 98.40, n=12n=12CagrilintideCagrilintide: Q1 98.14, median 99.11, Q3 99.46, n=12n=12PemvidutidePemvidutide: Q1 97.55, median 97.98, Q3 98.35, n=12n=12AOD-9604AOD-9604: Q1 97.95, median 98.30, Q3 98.72, n=11n=11PT-141 (Bremelanotide)PT-141 (Bremelanotide): Q1 99.05, median 99.31, Q3 99.43, n=11n=11MGFMGF: Q1 98.71, median 98.89, Q3 99.04, n=10n=10CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 98.18, median 98.29, Q3 98.60, n=10outlier 99.35n=10 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.